Terms: = Pancreatic cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Prognosis
13 results:
1. Targeting the Ntrk Fusion Gene in pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
Gupta M; Sherrow C; Krone ME; Blais EM; Pishvaian MJ; Petricoin EF; Matrisian LM; DeArbeloa P; Gregory G; Brown A; Zalewski O; Prinzing G; Roche C; Kanehira K; Mukherjee S; Iyer R; Fountzilas C
J Natl Compr Canc Netw; 2021 Jan; 19(1):10-15. PubMed ID: 33406492
[TBL] [Abstract] [Full Text] [Related]
2. [Ntrk Fusions: A new way of treatment for gastro-intestinal tumor?].
Ouali K; Pellat A; Cohen R; Svrcek M; Penault-Llorca F; André T
Bull Cancer; 2020 Apr; 107(4):447-457. PubMed ID: 32067719
[TBL] [Abstract] [Full Text] [Related]
3. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract] [Full Text] [Related]
4. Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of pancreatic cancer Cells.
Bapat AA; Munoz RM; Von Hoff DD; Han H
PLoS One; 2016; 11(10):e0165586. PubMed ID: 27792755
[TBL] [Abstract] [Full Text] [Related]
5. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up.
Nozières C; Chardon L; Goichot B; Borson-Chazot F; Hervieu V; Chikh K; Lombard-Bohas C; Walter T
Eur J Endocrinol; 2016 Mar; 174(3):335-41. PubMed ID: 26671974
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics of multiple endocrine neoplasia].
Conte-Devolx B; Niccoli P;
Bull Acad Natl Med; 2010 Jan; 194(1):69-78; discussion 78-9. PubMed ID: 20669560
[TBL] [Abstract] [Full Text] [Related]
7. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.
Dang C; Zhang Y; Ma Q; Shimahara Y
J Gastroenterol Hepatol; 2006 May; 21(5):850-8. PubMed ID: 16704535
[TBL] [Abstract] [Full Text] [Related]
8. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract] [Full Text] [Related]
9. Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells.
Okada Y; Eibl G; Guha S; Duffy JP; Reber HA; Hines OJ
Clin Exp Metastasis; 2004; 21(4):285-92. PubMed ID: 15554384
[TBL] [Abstract] [Full Text] [Related]
10. Expression of trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma.
Sakamoto Y; Kitajima Y; Edakuni G; Sasatomi E; Mori M; Kitahara K; Miyazaki K
Oncol Rep; 2001; 8(3):477-84. PubMed ID: 11295066
[TBL] [Abstract] [Full Text] [Related]
11. The trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract] [Full Text] [Related]
12. The novel trk receptor tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness.
Miknyoczki SJ; Dionne CA; Klein-Szanto AJ; Ruggeri BA
Ann N Y Acad Sci; 1999 Jun; 880():252-62. PubMed ID: 10415871
[TBL] [Abstract] [Full Text] [Related]
13. Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma.
Leboulleux S; Baudin E; Young J; Caillou B; Lazar V; Pellegriti G; Ducreux M; Schaison G; Schlumberger M
Eur J Endocrinol; 1999 Mar; 140(3):187-91. PubMed ID: 10216512
[TBL] [Abstract] [Full Text] [Related]
